Morgan Stanley Immunocore Holdings PLC Transaction History

Morgan Stanley

$1.39 Trillion
Q4 2024

A detailed history of Morgan Stanley transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Morgan Stanley holds 130,641 shares of IMCR stock, worth $3.82 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

130,641

Previous 404,825 67.73%

Holding current value

$3.82 Million

Previous $12.6 Million 69.43%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$28.14 - $34.69 $7.72 Million - $9.51 Million	-274,184 Reduced 67.73%	130,641 $3.85 Million
Q3 2024 Nov 14, 2024	SELL	$30.06 - $41.49 $13.9 Million - $19.3 Million	-464,039 Reduced 53.41%	404,825 $12.6 Million
Q2 2024 Oct 17, 2024	BUY	$33.78 - $63.75 $2.28 Million - $4.31 Million	67,590 Added 8.44%	868,864 $29.4 Million
Q2 2024 Aug 14, 2024	BUY	$33.78 - $63.75 $2.28 Million - $4.31 Million	67,590 Added 8.44%	868,864 $29.4 Million
Q1 2024 Oct 17, 2024	SELL	$60.14 - $75.36 $4.06 Million - $5.09 Million	-67,590 Reduced 7.78%	801,274 $52.1 Million
Q1 2024 Aug 16, 2024	SELL	$60.14 - $75.36 $6.96 Million - $8.73 Million	-115,789 Reduced 12.63%	801,274 $52.1 Million
Q1 2024 May 15, 2024	SELL	$60.14 - $75.36 $6.96 Million - $8.73 Million	-115,789 Reduced 12.63%	801,274 $52.1 Million
Q4 2023 Aug 16, 2024	BUY	$42.85 - $69.5 $2.07 Million - $3.35 Million	48,199 Added 5.55%	917,063 $62.7 Million
Q4 2023 Feb 13, 2024	SELL	$42.85 - $69.5 $1.89 Million - $3.06 Million	-44,025 Reduced 4.58%	917,063 $62.7 Million
Q3 2023 Nov 15, 2023	BUY	$49.5 - $66.6 $7.35 Million - $9.89 Million	148,466 Added 18.27%	961,088 $49.9 Million
Q2 2023 Aug 14, 2023	BUY	$48.54 - $61.64 $782,998 - $994,314	16,131 Added 2.03%	812,622 $48.7 Million
Q1 2023 May 15, 2023	BUY	$46.12 - $65.71 $20.4 Million - $29 Million	441,769 Added 124.54%	796,491 $39.4 Million
Q4 2022 Feb 14, 2023	BUY	$45.51 - $65.08 $9.33 Million - $13.3 Million	204,972 Added 136.88%	354,722 $20.2 Million
Q3 2022 Nov 14, 2022	BUY	$37.34 - $57.44 $4.72 Million - $7.26 Million	126,403 Added 541.41%	149,750 $7.03 Million
Q2 2022 Oct 27, 2022	BUY	$25.46 - $37.72 $534,532 - $791,931	20,995 Added 892.64%	23,347 $871,000
Q2 2022 Aug 15, 2022	BUY	$25.46 - $37.72 $534,532 - $791,931	20,995 Added 892.64%	23,347 $871,000
Q1 2022 Oct 27, 2022	SELL	$18.94 - $34.29 $397,645 - $719,918	-20,995 Reduced 89.93%	2,352 $70,000
Q1 2022 May 13, 2022	BUY	$18.94 - $34.29 $17,936 - $32,472	947 Added 67.4%	2,352 $70,000
Q4 2021 Feb 14, 2022	SELL	$27.58 - $40.0 $25,263 - $36,640	-916 Reduced 39.47%	1,405 $48,000
Q3 2021 Nov 15, 2021	BUY	$27.98 - $40.0 $64,941 - $92,840	2,321 New	2,321 $86,000

Others Institutions Holding IMCR

# of Institutions

125

Shares Held

42.5M

Call Options Held

79.9K

Put Options Held

46.2K

View Full List

About Immunocore Holdings plc

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.28B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

More about IMCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account